SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma’s arm launches Generic Glumetza Tablets in US

25 Jul 2018 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary has launched the generic versions of Glumetza (metformin hydrochloride) extended release tablets, 500 mg and 1000 mg in the US.

These generic Metformin HCI extended release tablets, 500mg and 1000mg are therapeutic equivalents of Santarus Inc.’s Glumetza HCI extended release tablets, 500 mg and 1000 mg. The addressable market size is approximately $ 443 million for the 12 months ending April 2018, as per IQVIA.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1619.95 -59.90 (-3.57%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×